Clinical Trial Update: Cisplatin + Radiation in SCCHN and Correlation With Oxidative Stress Markers [Phase 2]

View source ↗

Summary

Phase 2 study evaluating cisplatin with radiation in head and neck squamous cell carcinoma and examining its relationship with oxidative stress markers; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)

Snippet

Sponsor: Susanne Arnold | Conditions: Carcinoma, Squamous Cell, Head and Neck Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-10-14